Table 1 Demographic and clinic-pathological data for enrolled individuals.
Factors | Control N = 30 | Benign breast lesions N = 30 | Breast cancer N = 80 |
|---|---|---|---|
Age | |||
Median | 47 | 45 | 50 |
Mean ± SD | 50.7 ± 8 | 50 ± 8 | 51.4 ± 8 |
Menopausal status | |||
Pre-menopause | 14 | 15 | 40 |
Post-menopause | 16 | 15 | 40 |
Pathology status | --- | Fibroadenoma (n = 9) | DCIS (n = 33) IDC (n = 47) |
Follicular hyperplasia (n = 10) | |||
Intra-ductal papillomatosis (11) | |||
Clinical stage | --- | --- | |
Early stage | 35 | ||
Late stage | 45 | ||
Histological grade | --- | --- | |
Low grade | 31 | ||
High grade | 49 | ||
Lymph- node involvement | --- | --- | 34 |
Negative | |||
Positive | |||
ER-status | --- | --- | |
Negative | 41 | ||
Positive | 39 | ||
PgR-status | --- | --- | |
Negative | 39 | ||
Positive | 41 | ||
HER-2neu-status | --- | --- | |
Negative | 52 | ||
Positive | 28 |
